Albumin-bound paclitaxel from Kexing Biopharm receives EU marketing approval
Shenzhen, China (ots/PRNewswire) – On July 28, 2024, Kexing Biopharm announced the European Commission’s approval of Apexelsin®, the generic to Abraxane® (nab-paclitaxel) from Bristol Myers Squibb and Celgene. Apexelsin® was…